LTA anticorps

N° du produit ABIN2689811

Cet anticorps Souris Monoclonal détecte spécifiquement LTA dans WB et ELISA. Il présente une réactivité envers Humain et a été mentionné dans 1 publication.

Aperçu rapide pour LTA anticorps (ABIN2689811)

Antigène: LTA (Lymphotoxin-alpha (LTA))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp LTA est non-conjugé

Application: Western Blotting (WB), ELISA

Clone: 359-238

Détail du produit anti-LTA anticorps

Attributs du produit: The 359-238-8 antibody reacts with human lymphotoxin-α (LT-α, formerly known as TNF-β). The immunogen used to generate the 359-238-8 hybridoma was recombinant human LT-α. This is a neutralizing antibody. ELISA standard curve: Human LT-α

BD Pharmingen™ Purified Mouse Anti-Human LT-α - Purified - Clone 359-238-8 - Isotype Mouse IgG1 - Reactivity Hu - 1 mg

Purification: The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

Immunogène: Recombinant human LT-alpha

Isotype: IgG1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Concentration: 1.0 mg/mL

Buffer: Aqueous buffered solution containing ≤0.09 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: Store undiluted at 4°C.

Références pour anticorps anti-LTA (ABIN2689811)

Meager, Parti, Leung, Woolley, Peil, Sidhu, Roberts: "A two-site sandwich immunoradiometric assay of human lymphotoxin with monoclonal antibodies and its applications." dans: Journal of immunological methods, Vol. 104, Issue 1-2, pp. 31-42, (1988) (PubMed).

Détails sur LTA

Antigène: LTA (Lymphotoxin-alpha (LTA))

Autre désignation: LT-alpha

Classe de substances: Chemical

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process